Biochemistry, Genetics and Molecular Biology
Bevacizumab
50%
Brain Perfusion
50%
Choline
100%
Contrast
100%
Dynamics
100%
Magnetic Resonance Imaging
100%
Metabolic Pathway
100%
Perfusion
50%
Perfusion Magnetic Resonance Imaging
100%
Spectroscopic Imaging
50%
Volume
100%
Medicine and Dentistry
Antiangiogenic Therapy
100%
Assessment
16%
Bevacizumab
16%
Blood
100%
Brain Perfusion
16%
Choline
33%
Combination Therapy
16%
Differentiation
33%
Examination
16%
Follow up
16%
Glioblastoma
100%
Inpatient
100%
Lesion
33%
Magnetic Resonance Imaging
33%
Metabolism
100%
Metabolite
16%
Patient
50%
Perfusion
16%
Perfusion Weighted Imaging
33%
Treatment Response
16%
Neuroscience
Bevacizumab
33%
Brain
100%
Choline
66%
Glioblastoma Multiforme
100%
Magnetic Resonance Imaging
66%
N-Acetylaspartic Acid
66%